AbbVie Inc. — Director's Dealing 2016

Feb 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2016-02-18

Reporting Person: SEVERINO MICHAEL (EVP, R&D and CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-18	Option (right to buy)	$54.86	A	91990	Acquired	2026-02-17	Common stock (91990)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,664 on 02/18/2017, 30,663 on 02/18/2018, and 30,663 on 02/18/2019.